$ATYR

aTYR PHARMA INC

No enriched coverage for $ATYR in the last 7 days.

No SEC Form 4 filings for $ATYR in the last 30 days.

Low

ATYR Financials: Income Statement, Balance Sheet & Cash Flow

This article provides a detailed financial overview of Atyr Pharma Inc (ATYR), including its income statement, balance sheet, and cash flow statement, along with key financial ratios. It highlights the company's financial health signals, annual and quarterly metrics, and frequently asked questions about its performance. The analysis indicates weak overall financial health with low profitability and negative cash flow, despite strong liquidity and low leverage.

DEADLINE ALERT for MOH, MRX, ATYR, and WPP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - aTyr Pharma ( NASDAQ:ATYR ) , Molina Healthcare ( NYSE:MOH )

LOS ANGELES, Nov. 25, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

News on $ATYR